During the past decade, Albert Einstein Comprehensive Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 31 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albert Einstein Comprehensive Cancer Center" #1 sponsor was "Children's Oncology Group" with 41 trials, followed by "Eastern Cooperative Oncology Group" with 38 trials sponsored, "Radiation Therapy Oncology Group" with 19 trials sponsored, "National Cancer Institute (NCI)" with 13 trials sponsored and "Montefiore Medical Center" with 13 trials sponsored. Other sponsors include 74 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albert Einstein Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 157 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 7 trials as a collaborator and "The Emmes Company, LLC" with 7 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Albert Einstein Comprehensive Cancer Center" are "Leukemia" (24 trials), "Breast Cancer" (21 trials), "Lymphoma" (20 trials), "Sarcoma" (16 trials) and "Lung Cancer" (13 trials). Many other conditions were trialed in "Albert Einstein Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "Albert Einstein Comprehensive Cancer Center" are "Drug" (166 trials), "Biological" (57 trials), "Radiation" (49 trials), "Procedure" (38 trials) and "Other" (12 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (39 trials), "radiation therapy" (38 trials), "filgrastim" (29 trials), "etoposide" (28 trials) and "vincristine sulfate" (24 trials). Other intervention names were less common.

The vast majority of trials in "Albert Einstein Comprehensive Cancer Center" are 160 trials for "All" genders, 28 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Albert Einstein Comprehensive Cancer Center". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 176 completed trials in Albert Einstein Comprehensive Cancer Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Albert Einstein Comprehensive Cancer Center, 23 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".